Re: Cristina Masini, Cinzia Iotti, Ugo De Giorgi, et al. Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.09.016

2022 ◽  
Author(s):  
Giulio Francolini ◽  
Lucia P. Ciccone ◽  
Lorenzo Livi
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Metastatic Renal Cell Carcinoma ◽  
Stereotactic Body Radiotherapy ◽  
Renal Cell ◽  
Pretreated Patients

Phase II Trial of Low Dose γ -Interferon in Metastatic Renal Cell Carcinoma

1994 ◽  
Vol 152 (3) ◽  
pp. 841-845 ◽  
Author(s):  
Julie A. Ellerhorst ◽  
Robert G. Kilbourn ◽  
Robert J. Amato ◽  
Alexander A. Zukiwski ◽  
Elaine Jones ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Low Dose ◽  
Phase Ii Trial ◽  
Γ Interferon

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

2010 ◽  
Vol 66 (6) ◽  
pp. 1065-1070 ◽  
Author(s):  
Seiji Naito ◽  
Taiji Tsukamoto ◽  
Michiyuki Usami ◽  
Hiroyuki Fujimoto ◽  
Hideyuki Akaza
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Metastatic Renal Cell Carcinoma ◽  
Renal Cell ◽  
Early Phase ◽  
Phase Ii Trial ◽  
Japanese Patients
Sign in / Sign up

Export Citation Format

Share Document